681 Development of a Topical Hedgehog Inhibitor for Prevention of New Surgically Eligible Basal Cell Carcinomas in Patients With Gorlin Syndrome: Phase 3 Trial

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.757
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Patients

Journal of Skin Cancer
DermatologyOncology
2011English

Metastasis of Basal Cell Carcinoma to Lymph Nodes in a Patient With Gorlin Syndrome – And Literature Review

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

988 an Open-Label Phase 2 Clinical Trial of Topical Remetinostat Gel for Basal Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Basal Cell Nevus Syndrome (Gorlin-Goltz Syndrome): Genetic Predisposition, Clinical Picture and Treatment

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2017English

A Reappraisal of Cryosurgery for Eyelid Basal Cell Carcinomas

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2002English

Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod and Topical 5-Fluorouracil in Patients With Superficial Basal Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients With Refractory, Locally Advanced or Metastatic Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2011English

Phenotype and Genotype in 17 Patients With Goltz-Gorlin Syndrome

Journal of Medical Genetics
Genetics
2009English

Two Basal Cell Carcinomas of the Axillae: A Metastasis or an Independent Development?

Case Reports in Dermatological Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy